Integrated genomic and molecular characterization of cervical cancer.
about
Cervical Cancer Neoantigen Landscape and Immune Activity is Associated with Human Papillomavirus Master Regulators.PD-1/PD-L1 Blockade Therapy for Tumors with Downregulated MHC Class I Expression.Emerging role of mutations in epigenetic regulators including MLL2 derived from The Cancer Genome Atlas for cervical cancer.Human genomics projects and precision medicine.Comparative transcriptomes of adenocarcinomas and squamous cell carcinomas reveal molecular similarities that span classical anatomic boundariesUALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses.The future of oncology therapeutics.Network approaches to systems biology analysis of complex disease: integrative methods for multi-omics data.Computational Methods for Characterizing Cancer Mutational Heterogeneity.Molecular mechanisms of human papillomavirus-related carcinogenesis in head and neck cancer.Winding back Wnt signalling: potential therapeutic targets for treating gastric cancers.Worldwide burden of cancer attributable to HPV by site, country and HPV type.Molecular tests potentially improving HPV screening and genotyping for cervical cancer prevention.Analysis of Class I Major Histocompatibility Complex Gene Transcription in Human Tumors Caused by Human Papillomavirus Infection.HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis.Somatic Host Cell Alterations in HPV Carcinogenesis.Why does cervical cancer occur in a state-of-the-art screening program?Histopathologic follow-up and HPV test results with HSIL Papanicolaou test results in China's largest academic women's hospital.Cervical cancer metastasis to the brain: A case report and review of literature.A Comprehensive Infrastructure for Big Data in Cancer Research: Accelerating Cancer Research and Precision Medicine.MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis.Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.Structural complexity in the KCTD family of Cullin3-dependent E3 ubiquitin ligases.The Cancer Genomics Cloud: Collaborative, Reproducible, and Democratized-A New Paradigm in Large-Scale Computational Research.Human papillomavirus dysregulates the cellular apparatus controlling the methylation status of H3K27 in different human cancers to consistently alter gene expression regardless of tissue of originmiRTarBase update 2018: a resource for experimentally validated microRNA-target interactions.L1 cell adhesion molecule (L1CAM) is a strong predictor for locoregional recurrences in cervical cancer.Upregulation of homeobox gene is correlated with poor survival outcomes in cervical cancer.Using single-cell multiple omics approaches to resolve tumor heterogeneity.Human Papillomavirus 16 E7 Stabilizes APOBEC3A Protein by Inhibiting Cullin 2-dependent Protein Degradation.HPV integration hijacks and multimerizes a cellular enhancer to generate a viral-cellular super-enhancer that drives high viral oncogene expression.APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution.Surgical staging identified false HPV-negative cases in a large series of invasive cervical cancers.Prediction of outcome using pretreatment 18F-FDG PET/CT and MRI radiomics in locally advanced cervical cancer treated with chemoradiotherapy.ATF1 and RAS in exosomes are potential clinical diagnostic markers for cervical cancer.Somatic Superenhancer Duplications and Hotspot Mutations Lead to Oncogenic Activation of the KLF5 Transcription Factor.Pan-cancer analysis reveals presence of pronounced DNA methylation drift in CpG island methylator phenotype clusters.Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer.Clinical outcomes and differential effects of PI3K pathway mutation in obese versus non-obese patients with cervical cancer.The roles of pathology in targeted therapy of women with gynecologic cancers.
P2860
Q33806351-6FC13363-9C7D-424F-98CB-CB0EA637B0D7Q33839204-4C6F4335-56C4-4178-880F-94F6713D35EBQ36340870-1502939D-B858-4CFE-842E-2821365F09E4Q38626087-1D9EF8D9-9A5F-4FD9-85F6-EB43913B8076Q38634656-04587F34-E95E-41C2-A916-E11415114B1BQ38667837-89880CC3-8FEE-4DAD-B6DF-2F28D9D81747Q38683944-D761D40E-90F6-4241-937B-AACECC93761AQ38692645-3B459782-F46E-400D-9B78-7C20732FC8EBQ38703541-8FB07EB2-9ED8-4872-8063-CECB4C085ACFQ38723429-30CE0E86-32AD-4CCC-9ECC-05CBE00D9CE8Q38751688-F75976DA-FD15-4291-9B37-3563E51E99BAQ38859779-4986BABA-FA4A-4DE5-BBBF-5093A00A9E65Q39170424-1E9F1217-5FFB-4976-9A93-B4075EA1FFE5Q40047932-97B944E8-3A98-41C0-B272-4BD85D08ED54Q40050669-C625E636-9C43-493F-B8F1-B96EF128B82BQ40096622-C7BA2E25-AA11-43DC-B0C2-943E5D1A49B3Q40162758-2A6A94CE-7D2C-4C41-9CF0-2302C361D764Q40503813-C1571E4F-C080-429E-A570-FCDDAC15C6E8Q41506462-73B3A7E9-EB94-44DE-ACE2-D13C0B528BF3Q42103552-4051A03E-7943-42BF-8423-A3D219582268Q42278964-B1413D28-14FD-434F-80C8-35D48722F3CCQ42516513-A8121492-FF52-4022-9525-19A889B83293Q42694183-D0E1CE43-60C4-4145-9D9D-6B61C5A843FDQ42695262-CD7D02B7-94B8-4A89-B57D-9F59EE4E4BE3Q42700772-1498DF79-DA12-4947-83A6-D2AA45DB779EQ45944020-BB60E22E-DDA4-4EBA-9CCF-172DBAF37196Q47110513-E31769F9-108E-43D1-9CBC-F13A3F3EE981Q47132768-F6C03289-7F62-4967-BE84-7B77D6662792Q47236022-84DD594E-3470-423C-8C25-728F44347725Q47549187-62BCF774-B3F4-447F-AD53-B8B2B488BE86Q47549317-1FAF1DE6-67A5-4343-A5D9-534297D10689Q47555165-F24EF20E-0DDE-4C5E-9670-9D3BEE34F759Q47572365-1D1B47B7-C51B-4147-B6E6-E0D2B7CEFDE6Q47582480-36A061E0-E081-4A6B-B002-1E4F09DB52D7Q47662798-84CCAF6D-E41C-4236-B75F-BA8B587C3E51Q47723106-36B46244-976B-4E7D-887C-B1FEA3264F8AQ47902391-9EE0CF29-6C05-4499-93E0-DC5B00355CF9Q48297441-69913642-6FB6-4402-A6D9-40666A35B1ADQ49171619-B7FA0F9C-1249-4858-A129-F4BC67E4E8BBQ49645276-F3762BB9-4EE5-4D31-9FAE-6A6D2F1D4BDA
P2860
Integrated genomic and molecular characterization of cervical cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Integrated genomic and molecular characterization of cervical cancer.
@en
Integrated genomic and molecular characterization of cervical cancer.
@nl
type
label
Integrated genomic and molecular characterization of cervical cancer.
@en
Integrated genomic and molecular characterization of cervical cancer.
@nl
prefLabel
Integrated genomic and molecular characterization of cervical cancer.
@en
Integrated genomic and molecular characterization of cervical cancer.
@nl
P2093
P2860
P50
P356
P1433
P1476
Integrated genomic and molecular characterization of cervical cancer.
@en
P2093
Barretos Cancer Hospital
Cancer Genome Atlas Research Network
Eli &Edythe L. Broad Institute ...... Technology &Harvard University
Helen F. Graham Cancer Center &Research Institute at Christiana Care Health Services
HudsonAlpha Institute for Biotechnology
ILSbio, LLC
Institute for Systems Biology
Institute of Human Virology
International Genomics Consortium
Leidos Biomedical
P2860
P2888
P304
P356
10.1038/NATURE21386
P407
P50
P577
2017-01-23T00:00:00Z
P6179
1074205537